In the current study, we examined the concentrations of serum IL-33 and sST2 in patients with chronic hepatitis C (CHC), individuals with spontaneously resolved HCV infection (SR-HCV), and healthy controls (HC) to evaluate the potential role of IL-33/ST2 axis in the pathogenic process of CHC. This evidence concerns the gene IL33 and chronic hepatitis C virus infection.